Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke

Journal of Neural Transmission

Volumn 120, Issue 3, 2013, Pages 469-476

  Santamato, Andrea ^a   Panza, Francesco ^b   Ranieri, Maurizio ^c   Frisardi, Vincenza ^c   Micello, Maria Francesca ^a   Filoni, Serena ^a   Fortunato, Francesca ^a   Intiso, Domenico ^b   Basciani, Mario ^b   Logroscino, Giancarlo ^c   Fiore, Pietro ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Botulinum toxin type A free of complexing proteins; Disability; Higher doses; NT 201; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARM; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LEG; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SPASTICITY;

AGED; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; RECOVERY OF FUNCTION; STROKE; UPPER EXTREMITY;

EID: 84875732996     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0892-x     Document Type: Article

References (27)

1. Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785-793 (Pubitemid 41427518)
2. Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192:540-542
3. Baricich A, Carda S, Bertoni M, Maderna L, Cisari C (2008) A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 40:870-872
4. Barnes M, Schnitzler A, Medeiros L, Aguilar M, Lehnert-Batar A, Minnasch P (2010) Efficacy and safety of NT 201 for upper limb spasticity of various etiologies - a randomized parallel-group study. Acta Neurol Scand 122(4):295-302
5. Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949-1951 (Pubitemid 40800714)
6. Bovend'Eerdt TJ, Newman M, Barker K, Dawes H, Minelli C, Wade DT (2008) The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 89:1395-1406 (Pubitemid 351884984)
7. Brashear A, Zafonte R, Corcoran M, Galvez-Jimenez N, Gracies JM, Gordon MF, McAfee A, Ruffing K, Thompson B, Williams M, Lee CH, Turkel C (2002a) Inter- and intra-rater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb post stroke spasticity. Arch Phys Med Rehabil 83:1349-1354
8. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group (2002b) Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 347:395-400 (Pubitemid 34851831)
9. Carda S, Invernizzi M, Baricich A, Cisari C (2011) Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil 25:1119-1127
10. Dressler D (2009) Routine use of Xeomin in patients previously treated with Botox: long term results. Eur J Neurol 16(Suppl 2):2-5
11. Frevert J (2009) Xeomin is free from complexing proteins. Toxicon 54:697-701
12. Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C (2007) Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil 21:331-337 (Pubitemid 47064552)
13. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH (1996) Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 27:455-460 (Pubitemid 26081442)
14. Jankovic J, Schwartz K (1995) Response and immunoresistance to botulinum toxin injections. Neurology 45:1743-1746
15. Jost WH, Kohl A, Brinkmann S, Comes G (2005) Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers. J Neural Transm 112:905-913 (Pubitemid 40869079)
16. ®) in focal dystonia. Drugs 67:669-683 (Pubitemid 46535642)
17. Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I (2011) Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity. J Rehabil Med 43:486-492
18. Price DD, Bush FM, Long S, Harkins SW (1994) A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 56:217-226 (Pubitemid 24067851)
19. Roggenkamper P, Jost WH, Bihari K, Comes G, Grafe S (2006) Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303-312 (Pubitemid 43201097)
20. Rosales RL, Chua-Yap AS (2008) Evidence-based systematic review on the efficacy and safety of botulinum toxin - a therapy in post-stroke spasticity. J Neural Transm 115:617-623
21. Schwartzman RJ, Alexander GM, Grothusen J (2006) Pathophysiology of complex regional pain syndrome. Expert Rev Neurother 6:669-681 (Pubitemid 43964715)
22. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double blind, placebo controlled trial. Neurology 46:1306-1210
23. Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y (2009) Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 73:736-737
24. Sjölund BH (2002) Pain and rehabilitation after spinal cord injury: the case of sensory spasticity? Brain Res Brain Res Rev 40:250-256 (Pubitemid 36183174)
25. Slawek J, Bogucki A, Reclawowicz D (2005) Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Neurol Sci 26:32-39 (Pubitemid 40723939)
26. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N (2009) European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 41:13-25
27. Yelnik AP, Simon O, Parratte B, Gracies JM (2010) How to clinically assess and treat muscle overactivity in spastic paresis. J Rehabil Med 42:801-807